MarketsSingle-source
2.0
FreeCast, Inc. reports executive or director departure via 8-K filing
SEC EDGAR 8-K FilingsLO·US·1 day ago
NewAmsterdam Pharma filed an 8-K disclosing a change in leadership or board composition under Item 5.02. The filing confirms a departure or appointment, though specific names and roles remain to be detailed in the full document.